Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells
Stengel, Kristy R.
Feruglio, Paolo Fumene
Baker, Joshua N.
van der Laan, Anja M.
Di Carli, Marcelo
Hiebert, Scott W.
MetadataShow full item record
CitationDutta, Partha, Hendrik B. Sager, Kristy R. Stengel, Kamila Naxerova, Gabriel Courties, Borja Saez, Lev Silberstein, et al. 2015. “Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells.” Cell Stem Cell 16 (5) (May): 477–487. doi:10.1016/j.stem.2015.04.008.
AbstractFollowing myocardial infarction (MI), myeloid cells derived from the hematopoietic system drive a sharp increase in systemic leukocyte levels that correlates closely with mortality. The origin of these myeloid cells, and the response of hematopoietic stem and progenitor cells (HSPCs) to MI, however, is unclear. Here, we identify a CCR2+CD150+CD48− LSK hematopoietic subset as the most upstream contributor to emergency myelopoiesis after ischemic organ injury. This subset has 4-fold higher proliferation rates than CCR2−CD150+CD48− LSK cells, displays a myeloid differentiation bias, and dominates the migratory HSPC population. We further demonstrate that the myeloid translocation gene 16 (Mtg16) regulates CCR2+ HSPC emergence. Mtg16−/− mice have decreased levels of systemic monocytes and infarct-associated macrophages and display compromised tissue healing and post-MI heart failure. Together, these data provide insights into regulation of emergency hematopoiesis after ischemic injury and identify potential therapeutic targets to modulate leukocyte output after MI.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:17145839
- HMS Scholarly Articles